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ABSTRACT 
Our research seeks to identify a scrum profile, or serotype, that reflects the systemic phys-
iologic modifications resultant from dietary restriction (DR), in part such that this knowl-
edge can be applied for biomarker studies. Direct comparison suggests that component-based 
classification algorithms consistently out-perform distance-based metrics for studies of nu-
tritional modulation of metabolic serotype, but are subject to over-fitting concerns. Inter-
cohort differences in the sera metabolome could partially obscure the effects of DR. Further 
analysis now shows that implementation of component-based approaches (also called pro-
jection methods) optimized for class separation and controlled for over-fitting have >97% 
accuracy for distinguishing sera from control or DR rats. DR's effect on the metabolome is 
shown to be robust across cohorts, but differs in males and females (although some metabo-
lites are affected in both). We demonstrate the utility of projection-based methods for both 
sample and variable diagnostics, including identification of critical metabolites and samples 
that are atypical with respect to both class and variable models. Inclusion of non-statisti-
cally different variables enhances classification models. Variables that contribute to these 
models are sharply dependent on mathematical processing techniques; some variables that 
do not contribute under one paradigm arc powerful under alternative mathematical para-
digms. In practical terms, this information may find purpose in other endeavors, such as 
mechanistic studies of DR. Application of these approaches confirms the utility of megavari-
ate data analysis techniques for optimal generation of biomarkers based on nutritional mod-
ulation of physiological processes. 
INTRODUCTION 
DF E T A R Y R E S T R I C T I O N (DR) exerts protective effects against cancer (Yu. 1994; Weindruch and Watford, 1988) that appears dominant to genetics (Fernandes et al., 1995), carcinogen exposure (Kritchevsky et 
al., 1984), and specific components of the diet (Klurfeld et al., 1987). Although the majority of past re-
search on DR has focused on elucidating the underlying mechanisms by which it influences systemic 
processes of an organism, our fundamental aim has been to characterize a predictive model of DR through 
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analysis of the metabolome, in part so that these profiles could be used as biomarkers. Advances in high-
throughput screening techniques have facilitated the generation of large volumes of quantitative data. A 
practical application with respect to analysis of proteins is exemplified by studies that illustrate thai patho-
logical changes in ovarian cancer can be detected through algorithmic analysis of protcomic patterns in 
serum (Petricoin et al., 2002). Recent data suggest that, at least at the population level, markers associated 
with DR define segments of the population with distinctive longevity (Roth et al., 2002). 
Given that DR is a macronulrienl effect, we have predicted, and then provided support for, the concept 
that DR will be associated with shifts in the sera metabolome. Serotypes are being identified and charac-
terized using HPLC coupled with coulometric electrochemical array detectors (Vigncau-Callahan el al., 
2001; Shi et al., 2002a,b). Previous research has identified analytically valid metabolites (Vigneau-Calla-
han et al., 2001), demonstrated proof of principle (classification accuracy in the cohorts in which the mark-
ers were developed) (Shi et al., 2002b), and validated these markers in independent cohorts (Shi et al., 
2002a). The accompanying studies identified and partially eliminated inter-cohort differences in these mark-
ers and demonstrated thai these markers could comprise useful expert systems, ie they could be used to de-
velop algorithms capable of objective prediction (Shi et al., 2004; Paolucci et al., 2004). Perhaps not sur-
prisingly, work presented in these last two reports showed that the effects of DR on the metabolome are 
modulated by the gender of the animal and by environmental factors (strictly speaking, we have shown the 
double negative, that these markers are insufficiently robust as to be unaffected by these factors). Thus, al-
though the DR signal can be readily perceived mathematically in mixed derivation datascts, it is already 
apparent that more defined sample sets will yield stronger data. 
Earlier studies revealed the utility of component-based mathematical approaches (e.g., principal components 
analysis, PCA). also called projection methods, for a better generation, understanding, and utilization of meta-
bolic serotypes that reflect nutritional modulation (Shi et al.. 2()()2a.b). Projection methods have several qual-
ities that suggest their potential utility for the studies we wish to conduct (Eriksson el al., 2001; Manly, 2000). 
First, they compress large and complex dalascts by identifying linear mathematical combinations of variables 
that are capable of replacing the majority of a dataset. Second, they enable objective diagnostics of both ob-
servations (e.g., which samples are typical, which are not) and variables (e.g., which variables behave con-
sistently across datasets, and which do not). Third, projection methods can be used to build and/or optimize 
classification models, and these models can enable objective evaluation of both observations (e.g., which sam-
ples fit predicted categories and which do not) as well as variables (e.g., which variables contribute to distin-
guishing class, and which do not). Projection methods do, however, also have potential drawbacks, including 
their potential to over-fit models. (Soft Independent Modeling of Class Analogy | Wold, 19761, a supervised 
version of PCA, constructs models based on pre-defined |i.e., pre-assigncd, supervisedl samples, eg, an AL 
rat. While PCA calculates principal components on a whole data set, SIMCA generates principal component 
models for each training set class. Whereas PCA can only describe a dataset and thus provide visual infor-
mation as to the relationship between a new sample and members of the training sets, SIMCA predicts class 
membership of a new sample, or indicates that a new sample is not a member of the training classes.) In the 
accompanying study (Shi et al.. 2004), we showed that SIMCA-bascd models could distinguish sera derived 
from ad libitum (AL) fed animals from those undergoing DR, but that it also tended to derive models that are 
too specifically based on training set data (termed "overfilling" the models). 
Thus, we now address the question of whether component based approaches can be successfully optimized 
for generating metabolic serotypes that reflect DR and that could then be evaluated as biomarkers. This prob-
lem has three aspects that must be addressed: (1) Can we avoid over-fitting concerns without compromising 
the model? (2) Can we optimize the use of component-based models for classification purposes? (3) Can we 
deal with the inter-cohort and sex-specific differences that distinguish cohorts and lead to over-fitting? 
MATERIALS AND METHODS 
All aspects of the animal husbandry and basic HPLC analysis in this work have been previously pre-
sented (Vigneau-Callahan et al.. 2001; Shi el al.. 2002a,b). Data analysis presented was conducted using 
SIMCA-P9/P10 (Umetrics, Inc., Kinnelon. NJ). 
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RESULTS AND DISCUSSION 
Identification of serotypes to distinguish caloric intake 
In our initial studies, we focused on testing the effects of DR on the metabolome of each gender inde-
pendently. Single-cohort, single-gender studies were used to optimize power to identify those metabolites 
that might help distinguish AL and DR serotypes. For long-term use, however, we require serotypes with 
robust ability to distinguish caloric intake. To approach this problem, wc took the previously identified male 
and female serotypes and merged them, then removed extraneous metabolites based on overlap between the 
serotypes (Vigneau-Callahan et al.. 2001; Shi et al., 2002a,b). We further identified and removed metabo-
lites that were essentially represented twice in the dataset due to their dual reactivity on multiple channels 
of the coulometric array (termed back-waves; Paolucci et al., 2004). We further attempted to normalize each 
sample within each of these datasets to eliminate previous observed sensitivity to specific cohorts (the pro-
files and approaches used were sufficiently sensitive so as to separate not only AL from DR, but also each 
of the cohorts from which they were derived; Paolucci et al„ 2004). Normalization to serum tyrosine con-
centration eliminated —50% of the inlcr-cohort variation (Paolucci et al., 2004). 
Once completed, combining the data and normalization yield a profile composed of 93 metabolites that 
had been scored in both male and female rats from three independent cohorts. We further defined profiles 
based on whether metabolites had p values of <0.2 in males or females. This led to the creation of three 
profiles: (1) 93 metabolites, containing all metabolites originally identified as significant in either male or 
female rats; (2) 56 metabolites, containing the subset of the 93 metabolite profiles that had p values of <0.2 
in the combined female dataset. This data set is only used in studies of female rats; (3) 37 metabolites, con 
taining the subset of the 93 metabolite profiles that had p values of <0.2 in the combined male dataset. 
This data set is only used in studies of male rats. 
Cohort-specific effects 
Neither the 93 metabolite data set, or the two subsets optimized for gender-specific studies (37, 56 meta-
bolites), were free of cohort specificity (Fig. 1). Thus, neither normalization nor optimization eliminates the 
noise in the analysis introduced by cohort specific-effects on the metabolome. This noise is highlighted in 
Figure I, in which we clearly see the ability of PCA to distinguish the individual cohorts. This suggests 
that we need to turn to methods designed to focus on the separation between AL and DR. 
To ensure that the inter-cohort variability did not completely obscure the AL-DR signal, we re-examined 
male only and female only sets using PCA. These data clearly reveal that PCA is capable of partially dis-
tinguishing groups in both male and female rats, but that the increased noise from the different cohorts does 
considerably weaken the resolving power of this approach as compared with the previous studies that were 
based on single sexes and single cohorts. Furthermore, the use of the smaller "optimized" datasets did not 
aid in separation (not shown). 
Gender-specific effects 
A second issue arose as we looked in more depth at the relationships between gender and diet. As shown 
in the accompanying report, many (40/93, 43%) of the markers that we study differ by p < 0.01 between 
male and female animals when the animals are fed AL, but fewer (12/93, 13%) differ between the sexes 
when the animals arc maintained on DR feeding regimens. Coupled with other data presented in the ac-
companying paper, this result suggests that the ideal case—identifying truly sex-independent models for 
DR, is not feasible (or arguably, is not optimal), at least at this point. This point was addressed directly us-
ing PCA on combined data sets. These datasets could not be used to distinguish diet (not shown), because 
the mathematical planes of separation between AL and DR feeding groups are different in males and fe-
males (not shown). For this reason, the use of sex-blind (i.e., mixed sex) datasets will result in significant 
loss of resolving power. 
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(c) female samples modeled (d) female samples modeled 
with male/female data set with female data set 
FIG. 1. Principal components analysis (PCA) of male and female rats readily distinguish the three cohorts. PCA plots 
of the first three components based on 93 metabolites. Models were built on data sets comprised of combined male and 
female samples (a,c). male samples only (b) or female samples only (d). Rotated to show cohort distinctions. Letter 
labels refer to cohort of origin. In the legend, first letter designates cohort (A. B. C). second letter designates gender 
(M, F), the third and fourth letters refer to ad libitum (AL) or dietary restriction (DR). 
Mathematical pre-processing fails to eliminate cohort specificity 
We then sought to determine if we could eliminate the noise through mathematical means, specifically 
pre-processing. Pre-processing is a means for attempting to ensure "proper" (a context dependent issue) 
weighting for the variables. For the more basic levels of analysis, we examined this issue previously (Shi 
et al., 2002a,b), and found that Autoscaling the data [mean centering (subtracting the mean), followed by 
variance scaling (dividing by the standard deviation)] worked well. This approach was also followed in Fig-
ure I of this manuscript. It is possible, however, that other preprocessing mechanisms might help reduce 
the cohort problem. These methods might be sufficient, for example, if a major aspect of the difference be-
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tween. cohorts was simply a change in the variability of the overall cohort relative to a mean that was equiv-
alent to that of the other cohorts. Such an increase in variability might, for example, result from an increase 
in daily disturbances noise in the animal colony. We therefore systematically examined two aspects of pre-
processing—scaling and distribution. 
Scaling. We examined three scaling methods: no scaling, Pareto scaling, and unit variance (UV) scaling. 
No scaling is, as it sounds, using the raw numbers directly in the analysis. As the concentrations for each 
given metabolite (as determined by HPLC) are already standardized to the concentration of that given 
metabolite in a pooled serta sample used as a standard, the values being used are already somewhat stan-
dardized. In UV scaling, S1MCA-P9's equivalent of the Auto scale preprocessing described previously (from 
Pirouette), a given variable is centered on its mean and then divided by its standard deviation computed 
around that mean. Pareto scaling, which provides a level of manipulation that is in between no scaling and 
UV scaling, gives the variable a variance equal to its standard deviation instead of unit variance. Specifi-
cally, the variable is centered and divided by the square root of the standard deviation around the mean 
(Eriksson et al., 2001). No major differences were observed with the three scaling techniques (not shown). 
Specifically, we were essentially unable to separate AL and DR rats using PCA. 
Distributions. We next systematically examined six approaches designed to help the distribution: no ad-
justments, log transformation, winsorizing at two standard deviations, winsorizing at three standard devia-
tions, log transformation coupled with winsorizing at two standard deviations, and log transformation cou-
pled with winsorizing at three standard deviations. (Winsorizing is replacing a value that is beyond a 
mathematically defined limit with a predetermined, specific value. For example, replacing all observations 
greater than three standard deviations from the mean with the value at three standard deviations. This has 
the effect of reducing the impact of severe outliers on a model.) Log transformations improve signal dis-
tribution across datasets that are skewed or which have large minimum/maximum ratios. There were no 
major effects observed with the different methods of manipulating the distribution (not shown). We have 
also looked further, looking at all possible combinations with other scaling approaches. Overall, these means 
failed to remove the noise introduced by inclusion of multiple cohorts. 
Summary. The inability to correct the cohort separations using mathematical manipulations such as scal-
ing, transforms, normalizations, and winsorizing suggest that the cohort separations are biological, not an-
alytical, in nature. 
Evaluating mathematical proprocessing and its effects on PCA-hased analyses 
Subsequent analysis showed that no additional scaling was needed to develop models that were effective 
at describing metabolite concentrations (i.e., regenerating the values [concentrations] in the x-block [inde-
pendent variables, metabolites]; Figs. 2 and 3). In Figure 2, we consider all statistically valid PCA com-
ponents. This approach overfits the x-block with scaled data, but models the x-block well with no scaling, 
generating models with both good descriptive and predictive power. (The descriptive power of the model 
can be described by several terms, most directly [within SIMCA P] by R 2 X and R 2Xcum. These terms are 
defined within SIMCA-P as the fraction of the Sum of Squares [SS] of all the X's explained by the current 
component [R 2X] or the cumulative SS of all the X's explained by all extracted components R 2Xcum. These 
terms serve as the direct measure of the percentage of the total variability in the independent variables that 
is captured by the model. Likewise, Q 2 X and Q 2 Xcum serve as a measure of the fraction of the total vari-
ability of the independent variables that can be predicted by a given component [Q 2X] or by the overall 
model |Q 2 Xcum]. Q 2Icum] is computed as: Q 2cum = 11 - II(PRESS/SS)a| l a = | , „ . A ] , where IIJPRESS/ 
SS]a = the product of PRESS/SS for each individual component a, and the the prediction error sum of 
squares [PRESS] is the squared differences between observed and predicted values for the data kept out of 
the model fitting.) When the model is limited by only including components that increase predictive power 
(ie, Q 2 X>0, ) strong models are built with all scaling techniques, and near perfect models are built with no 
scaling. Note that descriptive mathematical models of the metabolome are essentially independent of the 
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FIG. 2. Unsealed PCA models out-perform scaled models. Parameters for all valid PCA components (Q2X>limit) 
(Eriksson et al., 2001). Plots shows males and females, all scaling and distribution methods. 
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FIG. 3, Unsealed PCA models still outperform scaled models when only components that add predictive power are 
considered. Parameters for all valid PCA components (Q 2X>0) (Eriksson et al., 2001). Plots shows males and females, 
all scaling and distribution methods. Numbers in brackets refer to those components having Q 2 X>0 relative to the to-
tal number of valid components (Q2X>limit). 
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choice of distribution modification (e.g., log transformation, winsorization) when only components having 
Q 2 X > 0 are used. 
Thus, we have explored PCA-based analyses and shown that they are (I) more robust for these studies 
than distance based metrics such as clustering-based algorithms (Shi et al., 2(X)2a,b, 2004); (2) robust across 
scaling techniques (Vigneau-Callahan et al.. 2001; Shi et al., 2002a,b; and above data); and (3) robust across 
different means of manipulating distributions when Q 2 X > 0 (Fig. 3). Despite these advantages, PCA ap-
pears unable to effectively separate AL and DR sera in sets from multiple cohorts. Likewise, wc have de-
termined that there are considerable differences in the effects of AL and DR feeding on male and female 
rats (Paolucci et al, 2004). Finally, while SIMCA-based expert system analysis consistently outperforms 
clustering-based k-nearest neighbor analyses, we have clear evidence that SIMCA also is weakened by the 
inter-cohort differences (Shi et al, 2004). Wc therefore make two decisions. First, we will continue (for 
now) to use the same set of metabolites to analyze male and female sera, but wc will build both predictive 
and descriptive models on each gender separately. Second, we will turn away from PCA to a projection 
method optimized for class separation. 
Partial least squares projection to latent structures-discriminant analysis {PLS-DA) 
PLS-DA versus SIMCA. Functionally, PLS-DA (Sjostrom et al., 1986; Stahle and Wold. 1987) may be 
considered the equivalent of finding a rotation of a multidimensional PCA space (or arguably, specifically 
creating the multidimensional space) so as to optimize the separation between classes of interest. This as-
pect of PLS-DA differentiates it from SIMCA, which focuses on the independent variables whose vari-
ability most underlies variation within the dataset, but which does not necessarily coincide with the maxi-
mum separation directions between the classes of interest. SIMCA builds models one class at a time (and 
thus classifies unknowns by whether or not they fit a given class), whereas PLS-DA builds models by iden-
tifying major differences that account for maximal co-variation between the X-block (metabolites/variables) 
and the "Y" values (i.e.. class membership; and thus classifies by class distinctions). Each has distinct ad-
vantages. For example, SIMCA can build more complex mathematical models. This feature enables SIMCA 
to correctly identifying group members when, for example, one group is entirely enveloped within another 
within a principal component space. PLS-DA's advantages include several that are directly applicable to 
the next stage of the analysis. These advantages, include strong over-fit diagnostics (categorical analysis 
programs can, as shown above, find solutions that are appropriate only for the training set); diagnostics 
present in the program used (SIMCA-P, Umetrics) readily enable us to monitor (and avoid) this potential 
concern. Secondly, specific variables can be readily monitored in PLS-DA for their importance in distin-
guishing groups, and prediction sets can be readily generated and tested in a more appropriate way (an en-
tire set can be tested and failures noted) than in SIMCA (in which only single sets can be tested). Finally. 
PLS-DA attempts to assign all variables to a class, whereas SIMCA is more likely to leave observations as 
unclassified, especially in early stages of modeling. For this reason, the next stage of analysis was con-
ducted with PLS-DA. 
We first examined the preprocessing and distribution considerations as done for PCA (Fig. 4). While "no 
scaling"' continued to model the X component well, it became obvious that both Pareto and UV scaling bet-
ter model the Y component (i.e., class, which are described as SIMCA-P by the terms R 2Y and Q 2 Y, which 
are determined as for their X equivalents, except looking at the fraction of Y that is modeled; Eriksson et 
al., 2001), and that log transformation yields only non-reproducible (i.e., non-predictive) models for non-
scaled data (Fig. 4). In particular. UV or Pareto scaling, coupled with log transformation and with win-
sorizing at 2 or 3 SD, seems very robust. To avoid losing the bottom of our distributions (those compounds 
present in very low concentrations relative to the mean concentration of that metabolite in the overall sam-
ple set) while capturing more of the variability al higher metabolite concentrations, we have chosen to UV 
scale and winsorize al 3 SD on the upper limit and 2 SD on the lower limit. These parameters are expected 
to provide a robust platform for further studies. 
PLS-DA models of AL versus DR serotype. To examine the potential methods in more detail, we now 
examine seven models built with the previous described data. Models I (Fig. 5) and 2 (Fig. 6) are, respec-
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FIG. 4. PLS-DA models built on scaled data capture class identity. Parameters for all valid PLS-DA components 
<Q2X>0) (Eriksson et al., 2001). Plots shows males and females, all scaling and distribution methods. 
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tivcly models of the male and female serotypes built on the markers having p S 0.2 in the cognate gender 
(37 markers in males; 56 markers in females). Models 5 and 6 (Figs. 7 and 8) use all 93 markers that were 
defined in either sex using an equivalent number of components (all of which have Q 2 Y > 0 ) , so that mod-
els built with the larger dataset can be directly compared to those built with the smaller dataset. Note the 
broader spread of useful metabolites in the larger models (i.e., the less significant peaks by univariate cri-
teria add considerably to multivariate analyses) Figure 9 uses a different preprocessing approach to show 
the existence of previously unidentified information in our metabolomics datasets. 
Each model (Figs. 5-9) is described/presented in the context of six panels. Panels A and B present data 
relevant to the strength of the models. Panel A shows the ability of the statistically valid components to 
capture the variability that distinguishes AL and DR serotypes. The first bar in each pair describing the 
component (termed R 2Ycum by SIMCA-P) is a quantitative measure of the goodness of fit, i.e., R 2Ycum 
is the overall proportion of the variation in the Y variable (here, AL vs. DR) that is explained by a model 
containing this and all previous components (R 2Y is that proportion explained by the specific component 
alone). Thus, the first bar in the second pair is a measure of the ability of this two-component model to ex-
plain the overall variation in the outcome variable (class, AL or DR). The second bar in each pair describ-
ing the component (termed Q 2 cum by SIMCA-P) is a quantitative measure of the predicted goodness of fit, 
by cross-validation, made by a model containing this and all previous components (Q 2 Y is that proportion 
explained by the specific component alone). (Cross-validation [CV| is implemented in SIMCA as follows: 
Parts of the data fas run, 1/7 of data per cycle] are kept out of model development, and then predicted by 
the model, and compared with the actual values. Specifically, the prediction error sum of squares [PRESS] 
is the squared differences between observed and predicted values for the data kept out of the model fitting. 
This procedure is repeated [seven times, as runj until every data element has been kept out once and only 
once. The final PRESS then has contributions from all data. For every dimension, SIMCA computes the 
overall PRESS/SS, where SS is the residual sum of squares of the previous dimension. SIMCA also com-
putes (PRESS/SS]k for each X variable [xk]. A component [model dimension] is considered significant if 
PRESS/SS is statistically smaller than 1.0.) Essentially by definition, R 2Ycum will increase with increas-
ing components, whereas Q 2Ycum will reach a threshold and then decline as the models become overfit. 
For PLS studies, a component is considered significant when Q 2 Y > 0 (i.e., when the component adds to the 
predictive strength of the model, termed rule Rl , the initial testing rule). All components in all models 
shown are considered significant by rule Rl . Panel B presents the permutation validation of the model. This 
validation test consists of randomizing the Y variables (i.e., class membership), building a new PLS-DA 
model, and re-evaluating accuracy. In every case, we conducted 100 permutation tests, and in all 100 tests 
of each model our model based on actual data was better than all 100 permutated models, essentially giv-
ing a p value of p < 0.01 to each model. We note that another criteria is that models are considered valid 
for their ability to describe variation when the Y intercept of R 2 Y, the top line, is <0.3-0.4. The four com-
ponent models are considerably overfit with respect to R 2 Y (not shown), and some smaller models approach 
or slightly exceed overfit conditions. This does suggest a need for caution in interpreting fit of a specific 
rat to a specific class. However, the more general predictive parameter, i.e., the ability of the model to pre-
dict group/class membership (the more important determinant for our purposes) is considered valid when 
FIG. 5. PLS-DA based classification of males based on the 37 metabolite dataset. PLS-DA models were built on UV 
scaled data winsorized at 2 SD (lower limit) and 3 SD (upper limit). (A) Parameters of the model. R2Y is the amount 
of variability of the Y variable (i.e., of class, AL vs. DR) of the overall dataset explained. Q2Y is the predicted accu-
racy of the model based on coefficients of variations from a scries of 7 jack-knifing (multiple sample leave out) analy-
ses. (B) Validate plot, results of 100 permutations of the Y variable. Correlation with actual dataset on X-axis: R2Y 
and Q2Y for each permutation on Y-axis. Shown with regression lines. (C) Plot based on the one statistically signifi-
cant component. Dashed line added to emphasize AL/DR distinction. (D) Weights plot showing the direction in which 
different metabolites pull the model. This plot is the PLS-DA equivalent of a loadings plot in PCA. (E) variable im-
portance on projection. X-axis lists metabolites by retention time. (F) Predicted vs. actual class assignments. Overall 
accuracy was >97%. 
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Var ID (Primary) Predicted AL probability 
FIG. 6. PLS-DA based classification of females based on the 56 metabolite dataset. Sec legend to Figure 5. Note that 
in plot in panel C for this figure, the figure is based on two statistically significant components. 
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FIG. 7. PLS-DA based classification of males based on the first component of 93 metabolite datasct. See legend to 
Figure 5. Overall accuracy >97%. 
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FIG. 8. PLS-DA based classification of females based on the first three components of the 93 metabolite dataset. See 
legend to Figure 5. Overall accuracy >97%. 
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Var ID (Primary) Predicted AL probability 
FIG. 9. PLS-DA based classification of females based on the 93 metabolite dataset (unsealed). Sec legend to Figure 
5. Overall accuracy >97%. Note, however, the poor separation between AL and DR classes, which are approximately 
located al the origin. 
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the y intercept of Q 2 Y, the bottom line, is <0.05. All models meet this criteria, thus no models are con-
sidered ovcrfit with respect to their predicted classification power, Q 2 Y. 
Panel C graphically presents the location in the model space of each animal with respect to component 
1 and 2 (panel C). These graphs highlight the separability of AL and DR rats. 
Panels E and F present information on the metabolites themselves. The data in Panel D shows how each 
of the individual analytes affects, or "pulls" the model. Metabolites whose influence maps in the same di-
rection (from the origin) as the diet's serotype pull the model in that direction as they become present in 
greater quantities. Distance from origin indicates the strength of that pull. A complementary plot is shown 
in Panel E (variable importance on projection, VIP).* VIP is a marker of how well each analyte separates 
the groups of interest (AL and DR) across the sum of all active components. Analytes having VIPs>l are 
considered the most important for separtions. Note that this analysis suggests 24 analytes contain the bulk 
of classification power in males and 34 in females. There are 11 overlaps between these two groups (not 
significant by consideration of binomial distribution). 
Panel H shows class membership. The score on the X-axis is predicted membership; the score on the 
Y-axis is actual membership. Formally, the test is membership or not for the tested class (the class on the 
top having a value of — I on the upper axis). 
The results obtained from these models may be summarized as follows: 
1. The models produced are mathematically robust/statistically valid. 
2. The data processing approaches (scaling and distribution) are valid. 
3. PLS-DA is superior to PCA for these studies because of its ability to ignore interference resulting from 
inter-cohort variation. 
4. PLS-DA generates strong, statistically valid models that have > 9 7 % accuracy in distinguishing AL and 
DR sera. 
5. Relatively few variables have VIP scores > 1 , suggesting the possibility that we can shrink the datasets 
being analyzed (but see below). 
We note that both the male and female dataset display disproportionately powerful variables (one each 
in males and females). This observation raises a potential issue as to whether the presence of these vari-
ables is the sole determinant of the differences between AL and DR serotypes. To address this issue, we 
excluded these variables and re-analyzed the data. The models remained capable of distinguishing AL and 
DR rats (not shown). 
At first glance, the combination of (A) few variables having high VIP scores and (B) the ability to re-
move the highest VIP score without compromising separation appear potentially mutually exclusive. Fur-
ther study of the VIP scores derived from the study in which the strongest marker was removed suggested 
that other markers now distinguished AL and DR serotypes. 
This result suggested to us that there might be markers that could help differentiate AL and DR, but 
whose effect was masked by the power of other markers. This hypothesis was confirmed by changing the 
scaling (from UV to no scaling), and redoing the PLS-DA (Fig. 9). Under these conditions, PLS-DA still 
distinguished AL and DR female rats, but the distribution of VIP values was markedly different, and the 
second and third strongest markers in Figure 9 had VIP values < 1 in Figure 8; indeed, marker 48.808 was 
actually the least valuable marker in Figure 8. This finding suggests that hidden information within the 
dataset exists and will require further analysis. 
*"SIMCA computes the influence on Y of every term (xk) in the model called VIP. VIP is the sum over all model 
dimensions of the contributions VIN (variable influence). For a given PLS dimension, a, (VINak2 is equal to the squared 
PLS weight (wak)2 of that term, multiplied by the explained SS of that PLS dimension. The accumulated (over all PLS 
dimensions) value, VIP ; )k - £ a VINk is then divided by the total explained SS by the PLS model and multiplied by the 
number of terms in the model. The final VIP is the square root of lhat number. The Sum of squares of all VIP's is 
equal to ihe number of terms in the model hence the average VIP would be equal lo 1. One can compare the VIP of 
one term to the others. Terms with large VIP, larger than 1, are the most relevant for explaining Y," 
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CONCLUSION 
In this report, we turn away from component based approaches that describe either the entire dataset (e.g., 
PCA) and/or specific classes (SIMCA), to a modeling approach that instead focuses on identifying the com-
ponents that best distinguish two defined classes (in this report, we focus on PLS-DA). The strength of PCA 
as a data analysis approach is that it can, relatively objectively, describe the major sources of variation in 
a population. The weighting of these variables on the components of a PCA-based representation, however, 
does not necessarily coincide with an outcome variable of interest. The great strength of SIMCA as a data 
analysis approach is, in contrast, that it builds a series of models each based on one class. By focusing on 
one class at a time, SIMCA thus allows more appropriate description on each class. While such an approach 
has advantages, it also has a major disadvantage in that, because it considers the groups independently, 
SIMCA can thus often underweight variables that can be particularly useful for classification because they 
don't explain a lot of variation within their own class. A complementary approach, termed PLS-DA, fo-
cuses instead on the analytes that are best able to distinguish classes. Because PLS-DA takes the entire 
dataset into consideration, but then focuses on the changes that reflect class, it can theoretically be used to 
see a specific signal (e.g., AL-DR serotype differences) in the context of noise (e.g., male-female differ-
ences, cohort distinctions). The use of PLS-DA in the study presented here thus shows that DR does exert 
different effects on the sera metabolome of males and females. Furthermore, PLS-DA analysis identifies a 
clear signal representing the effects of DR on the sera metabolome, which is robust across cohorts. 
In summary, we return to the three questions raised at the end of the introduction: (1) Can we avoid over-
fitting concerns without compromising the model? (2) Can we optimize the use of component-based mod-
els for classification purposes? (3) Can we deal with the inter-cohort and sex-specific differences that dis-
tinguish cohorts and lead to over-fitting? In all three cases, PLS-DA solves the problems resulting from 
inter-cohort variation, and allows us to build strong models defining metabolic serotype. This conclusion, 
however, was not readily apparent at the onset of analysis and required initial exploration the data set by 
means of PCA. Only after identification of the shortcomings inherent in PCA when applied to metabolomics 
data were we able to demonstrate the requirement for implementing a technique (i.e., PLS-DA) that would 
remedy these failures. 
ACKNOWLEDGMENTS 
We thank Dr. Tom Vogl for his many critical discussions and comments on the manuscript. 
REFERENCES 
ERIKSSON, L., JOHANSSON, E., KETTANEH-WOLD, N., et al. (2001). Multi- and Megavariate Analysis (Umea, 
Sweden, Umetrics). 
FERN ANDES, G., CHANDRASEKAR, B., TROYER. D.A., et al. (1995). Dietary lipids and calorie restriction affect 
mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl 
Acad Sci USA 92, 6494-6498. 
KLURFELD. D.M., WEBER, M.M., and KRITCHEVSKY, D. (1987). Inhibition of chemically induced mammary and 
colon tumor promotion by caloric restriction in rats fed increased dietary fat. Cancer Res 47, 2759-2762. 
KRITCHEVSKY, D., WEBER, M.M., and KLURFELD, D.M. (1984). Dietary fat versus caloric content in initiation 
and promotion of 7,12-dimethy)benz(a)anihracene-induced mammary tumorigenesis in rats. Cancer Res 44, 
3174-3177. 
MANLY, B.F.J. (2000). Multivariate Statistical Methods (Boca Raton, FL. CRC Press). 
PAOLUCC1, U.. VIGNEAU-CALLAHAN, K.E., SHI, H., et al. (2004). Development of biomarkers based on diet-de-
pendent metabolic serotypes: characteristics of component-based models of metabolic serotypes. OMICS 8, 209-220. 
PETRICOIN, E.F., ARDEKANI, A.M., HITT, B.A., et al. (2002). Use of proteomic patterns in serum to identify ovar-
ian cancer. Lancet 359, 572-577. 
ROTH, G.S., LANE, M.A., INGRAM, D.K., et al. (2002). Biomarkers of caloric restriction may predict longevity in 
humans. Science 297, 811. 
237 
PAOLUCCI ET AL. 
SHI, H., VIGNEAU-CALLAHAN. K.E., SHESTOPALOV, A.I., et al. (2002a). Characterization of diet-dependent 
metabolic serotypes: primary validation of male and female serotypes in independent cohorts of rats. J Nutr 132, 
1039-1046. 
SHI, H., VIGNEAU-CALLAHAN, K.E., SHESTOPALOV, A.I., et al. (2002b). Characterization of diet-dependent 
metabolic serotypes: Proof of principle in female and male rats. J Nutr 132, 1031-1038. 
SHI, H., PAOLUCCI, U.. VIGNEAU-CALLAHAN, K.E., et al. (2004). Development of biomarkers based on diet-de-
pendent metabolic serotypes: practical issues in development of expert system-based classification models in 
metabolomic studies. OMICS 8, 197-208. 
VIGNEAU CALLAHAN, K.E., SHESTOPALOV, A.I., MILBURY, P.E.. et al. (2001). Characterization of dict-dc-
pendent metabolic serotypes: analytical and biological variability issues in rats. J Nutr 131, 924S-932S. 
SJOSTROM, M.. WOLD, S., and B. SODERSTROM, B. (1986). PLS discriminant plots. In Pattern Recognition in 
Practice II. E.S. Gclscma and L.N. Kanal. eds. (Elsevier, Amsterdam), p. 486. 
STAHLE, L., and WOLD, S. (1987). Partial least squares analysis with cross-validation for the two-class problem: a 
Monte Carlo study. J Chemometrics 1, 185-196. 
WEINDRUCH, R., and WALFORD, R. (1988). The Retardation of Aging and Disease by Dietary Restriction (St. Louis, 
Charles C. Thomas). 
WOLD, S. (1976). Pattern recognition by means of disjoint principal components models. Pattern Recognition 8, 
127-139. 
YU, B.P. (1994). Modulation of Aging Processes by Dietary Restriction (Boca Raton, FL, CRC Press). 
Address reprint requests to: 
Dr. Bruce S. Krisial 
Dementia Research Service 
Burke Medical Research Institute 
785 Mamaroneck A ve. 
White Plains, NY 10605 
E-mail: Bkristal@burke.org 
238 
